Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yasuchika Hasegawa

Chief Executive Officer, President and Representative Director, Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 33 board members in 2 different organizations across 1 different industries.

See Board Relationships
66--

Background*

Mr. Yasuchika Hasegawa has been the President at Takeda Chemical Industries Ltd (Takeda Pharmaceutical Co. Ltd.) since June 27, 2003 and has been its Chief Executive Officer since 2009. Mr. Hasegawa served as Chief Operating Officer at Takeda Chemical Industries Ltd. since June 27, 2003 and also has been its Representative Director since 2003. He has been the Chairman at Keizai Doyukai (Japan Association of Corporate Executives) since 2011. He served as Vice Chairman ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-Chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

Chairman
2003-Present
Chief Executive Officer, President and Representative Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥4,745.00 JPY -55.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.6M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Karl-Ludwig Kley Chairman of the Executive Board and General Partner
Merck KGaA
€3.9M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.